Tenet Healthcare THC
$263.19 −$0.40 (-0.15%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $263.19 0.00%
Open$265.14
Prev close$263.59
Day range$261.15 – $266.62
Volume705.0K
Market cap$20.95B
P/E (TTM)7.7
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$6.28B+18.7% YoY
Operating profit$1.72B+110.5% YoY
Net profit$1.22B+110.5% YoY
Diluted EPS$12.41+221.5% YoY
Free cash flow$1.08B+39.2% YoY
Operating cash flow$1.28B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin83.3%
Operating margin22.5%
Net margin12.3%
Return on equity61.3%
Return on assets9.5%
Return on invested capital19.8%
Current ratio1.58
Liabilities / assets69.6%
Cash & investments$2.67B
Total debt$13.24B
Net cash (debt)-$10.57B
Free cash flow / sales14.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $6.28B | $6.04B | $5.78B | $21.31B | $5.53B |
| Cost of Revenue | $983.00M | $984.00M | $961.00M | $3.78B | $1.01B |
| Gross Profit | $5.29B | $5.06B | $4.82B | $17.53B | $4.52B |
| Operating Expense | $3.57B | $3.62B | $3.53B | $14.09B | $3.65B |
| Selling and Admin Expenses | $2.17B | $2.23B | $2.17B | $8.71B | $2.22B |
| -General & Admin Expense | $2.17B | $2.23B | $2.17B | $8.71B | $2.22B |
| Depreciation & Amortization & Depletion | $217.00M | $215.00M | $229.00M | $863.00M | $231.00M |
| -Depreciation & Amortization | $217.00M | $215.00M | $229.00M | $863.00M | $231.00M |
| Other Operating Expenses | $1.18B | $1.17B | $1.12B | $4.52B | $1.20B |
| Operating Profit | $1.72B | $1.44B | $1.30B | $3.44B | $869.00M |
| Net Non-Operating Interest Income (Expense) | -$203.00M | -$204.00M | -$205.00M | -$821.00M | -$205.00M |
| Non-Operating Interest Expense | $203.00M | $204.00M | $205.00M | $821.00M | $205.00M |
| Other Income (Expense) | $62.00M | $107.00M | $42.00M | $182.00M | $17.00M |
| Earnings from Equity Interest | $64.00M | $65.00M | $51.00M | $264.00M | $83.00M |
| Special Income (Charges) | -$39.00M | -$1.00M | -$50.00M | -$199.00M | -$103.00M |
| -Less:Other Special Charges | $11.00M | $3.00M | $27.00M | $83.00M | $49.00M |
| -Less:Write Off | $37.00M | $31.00M | $7.00M | – | – |
| -Gain on Sale Of Business | $9.00M | $33.00M | $1.00M | -$1.00M | -$5.00M |
| Other Non-Operating Income (Expenses) | $37.00M | $43.00M | $41.00M | $117.00M | $37.00M |
| Pretax Profit | $1.58B | $1.34B | $1.13B | $2.80B | $681.00M |
| Tax | $360.00M | $295.00M | $226.00M | $433.00M | $37.00M |
| Net Profit | $1.22B | $1.05B | $906.00M | $2.37B | $644.00M |
| Profit from Continuing Operations | $1.22B | $1.05B | $906.00M | $2.37B | $644.00M |
| Minority Interests | $219.00M | $219.00M | $204.00M | $960.00M | $273.00M |
| Net Income to Parent Company | $1.00B | $826.00M | $702.00M | $1.41B | $371.00M |
| Net Income to Common Stockholders | $1.00B | $826.00M | $702.00M | $1.41B | $371.00M |
| Basic EPS | $12.48 | $9.89 | $8.09 | $15.61 | $4.25 |
| Diluted EPS | $12.41 | $9.84 | $8.01 | $15.49 | $4.22 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | – | – | $17.00M | $54.00M | $1.00M |
| Total Revenue as Reported | – | – | – | $21.31B | $5.53B |
| -Less:Impairment of Capital Assets | – | – | – | $61.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $31.59B | $30.68B | $31.20B | $29.68B | $29.68B |
| Total Current Assets | $8.43B | $7.83B | $8.36B | $7.85B | $7.85B |
| Cash and Cash Equivalents & Short-Term Investments | $2.67B | $2.17B | $2.97B | $2.88B | $2.88B |
| -Cash and Cash Equivalents | $2.67B | $2.17B | $2.97B | $2.88B | $2.88B |
| Receivables | $4.55B | $4.62B | $4.36B | $3.86B | $3.86B |
| -Accounts Receivable | $2.60B | $2.61B | $2.61B | $2.57B | $2.57B |
| -Notes Receivable | $434.00M | $414.00M | $395.00M | – | – |
| -Other Receivables | $1.52B | $1.60B | $1.36B | $1.29B | $1.29B |
| Prepaid Assets | $360.00M | $338.00M | $351.00M | $423.00M | $423.00M |
| Inventory | $340.00M | $338.00M | $343.00M | $348.00M | $348.00M |
| Other Current Assets | $443.00M | $300.00M | $271.00M | $278.00M | $278.00M |
| Total Non-Current Assets | $23.16B | $22.85B | $22.85B | $21.83B | $21.83B |
| Net PPE | $6.29B | $6.26B | $6.25B | $7.45B | $7.45B |
| -Gross PPE | $13.35B | $13.18B | $13.07B | $14.13B | $14.13B |
| -Accumulated Depreciation | -$7.06B | -$6.92B | -$6.81B | -$6.68B | -$6.68B |
| Goodwill and Other Intangible Assets | $12.87B | $12.72B | $12.70B | $12.55B | $12.55B |
| -Goodwill | $11.64B | $11.44B | $11.39B | $11.20B | $11.20B |
| -Other Intangible Assets | $1.23B | $1.28B | $1.32B | $1.35B | $1.35B |
| Non-Current Deferred Assets | $49.00M | $71.00M | $84.00M | $84.00M | $84.00M |
| Other Non-Current Assets | $3.96B | $3.80B | $3.81B | $54.00M | $54.00M |
| Total Liabilities | $22.00B | $21.98B | $22.35B | $20.70B | $20.70B |
| Total Current Liabilities | $5.32B | $5.57B | $6.15B | $4.46B | $4.46B |
| Payables | $1.41B | $1.44B | $1.58B | $1.36B | $1.36B |
| -Accounts Payable | $1.39B | $1.37B | $1.34B | $1.36B | $1.36B |
| -Total Tax Payable | $22.00M | $69.00M | $236.00M | $0.00 | $0.00 |
| Current Accrued Expenses | $213.00M | $113.00M | $256.00M | $81.00M | $81.00M |
| Short-Term Debt and Capital Lease Obligation | $164.00M | $160.00M | $81.00M | $79.00M | $79.00M |
| -Current Debt | $164.00M | $160.00M | $81.00M | $79.00M | $79.00M |
| Current Provisions | $317.00M | $292.00M | $303.00M | $276.00M | $276.00M |
| Other Current Liabilities | $2.34B | $2.70B | $3.08B | $1.81B | $1.81B |
| Total Non-Current Liabilities | $16.68B | $16.41B | $16.20B | $16.24B | $16.24B |
| Long Term Debt and Capital Lease Obligation | $13.08B | $13.09B | $13.13B | $13.09B | $13.09B |
| -Long Term Debt | $13.08B | $13.09B | $13.13B | $13.09B | $13.09B |
| Non-Current Liabilities | $979.00M | $978.00M | $938.00M | $951.00M | $951.00M |
| Non-Current Deferred Liabilities | $529.00M | $325.00M | $199.00M | $240.00M | $240.00M |
| Employee Benefits | $238.00M | $241.00M | $243.00M | $245.00M | $245.00M |
| Other Non-Current Liabilities | $1.86B | $1.78B | $1.69B | $1.71B | $1.71B |
| Total Equity | $9.59B | $8.70B | $8.85B | $8.97B | $8.97B |
| Stockholders' Equity | $5.44B | $4.66B | $4.81B | $4.22B | $4.22B |
| Capital Stock | $8.00M | $8.00M | $8.00M | $8.00M | $8.00M |
| -Common Stock | $8.00M | $8.00M | $8.00M | $8.00M | $8.00M |
| Additional Paid-In Capital | $5.24B | $5.19B | $5.12B | $4.91B | $4.91B |
| Retained Earnings | $6.94B | $5.94B | $5.12B | $4.42B | $4.42B |
| Less: Treasury Stock | -$6.57B | -$6.31B | -$5.26B | -$4.94B | -$4.94B |
| Gains/Losses Not Affecting Retained Earnings | -$178.00M | -$177.00M | -$179.00M | -$181.00M | -$181.00M |
| Minority Interests | $4.15B | $4.04B | $4.04B | $4.75B | $4.75B |
| Investments and Advances | – | – | – | $1.44B | $1.44B |
| -Available for Sale Securities | – | – | – | $59.00M | $59.00M |
| -Long Term Equity Investment | – | – | – | $1.38B | $1.38B |
| Non Current Accounts Receivables | – | – | – | $203.00M | $203.00M |
| Non-Current Prepaid Assets | – | – | – | $50.00M | $50.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.28B | $585.00M | $1.64B | $3.54B | $731.00M |
| Net cash flow from continuing operations | $1.28B | $585.00M | $1.64B | $3.54B | $731.00M |
| Net Income from Continuing Operations | $1.22B | $1.05B | $906.00M | $2.37B | $644.00M |
| Gain/Loss from Continuing Operations | -$4.00M | -$72.00M | $27.00M | -$33.00M | -$16.00M |
| Depreciation & Depletion & Amortization | $217.00M | $215.00M | $229.00M | $863.00M | $231.00M |
| Deferred Tax | $227.00M | $137.00M | -$40.00M | $9.00M | -$42.00M |
| Other Non-Cash Items | -$47.00M | -$9.00M | -$6.00M | $29.00M | $66.00M |
| Change in Working Capital | -$441.00M | -$785.00M | $493.00M | $140.00M | -$172.00M |
| -Change in Receivables | $22.00M | -$5.00M | -$28.00M | $20.00M | -$48.00M |
| -Change in Inventory | -$38.00M | -$158.00M | $407.00M | -$73.00M | -$15.00M |
| -Change in Payables and Accrued Expense | -$404.00M | -$493.00M | -$145.00M | $209.00M | -$28.00M |
| -Change in Other Current Liabilities | $10.00M | $36.00M | $0.00 | $9.00M | -$41.00M |
| -Change In Other Working Capital | -$31.00M | -$165.00M | $259.00M | -$25.00M | -$40.00M |
| Net cash flow from investing | -$298.00M | -$203.00M | -$317.00M | -$1.28B | -$389.00M |
| Net Cash Flow from Continuing Investing Activities | -$298.00M | -$203.00M | -$317.00M | -$1.28B | -$389.00M |
| Net PPE Purchase and Sale | -$193.00M | -$164.00M | -$178.00M | -$972.00M | -$344.00M |
| Net Business Purchase and Sale | -$71.00M | -$9.00M | -$121.00M | -$308.00M | -$42.00M |
| Net Investment Purchase and Sale | -$30.00M | -$22.00M | -$4.00M | $3.00M | -$2.00M |
| Net Other Investing Changes | -$4.00M | -$8.00M | -$14.00M | $2.00M | -$1.00M |
| Financing Cash Flow | -$479.00M | -$1.18B | -$1.24B | -$2.40B | -$434.00M |
| Net Cash Flow from Continuing Financing Activities | -$479.00M | -$1.18B | -$1.24B | -$2.40B | -$434.00M |
| Net Issuance Payments Of Debt | -$15.00M | -$12.00M | -$19.00M | -$96.00M | -$27.00M |
| Net Common Stock Issuance | -$255.00M | -$1.04B | -$318.00M | -$1.39B | -$198.00M |
| Net Other Financing Charges | -$209.00M | -$125.00M | -$903.00M | -$919.00M | -$209.00M |
| Ending Cash Balance | $2.67B | $2.17B | $2.97B | $2.88B | $2.88B |
| Net Change in Cash | $504.00M | -$797.00M | $84.00M | -$136.00M | -$92.00M |
| Beginning Cash Balance | $2.17B | $2.97B | $2.88B | $3.02B | $2.98B |
| Free Cash Flow | $1.08B | $417.00M | $1.46B | $2.53B | $367.00M |
No comments yet — be the first to weigh in on THC.
Sign in to join the discussion.